Century(SZ:300078) Xin Lang Cai Jing·2025-12-22 01:32Group 1 - The core viewpoint of the news is that Sichuang Medical's stock performance and financial metrics indicate a mixed outlook, with notable fluctuations in financing activities and shareholder statistics [1][2]. Group 2 - On December 19, Sichuang Medical's stock fell by 1.14%, with a trading volume of 425 million yuan. The financing buy-in amount for the day was 18.70 million yuan, while the financing repayment was 16.07 million yuan, resulting in a net financing buy of 2.63 million yuan. The total financing and securities balance reached 156 million yuan [1]. - The financing balance of Sichuang Medical is 156 million yuan, accounting for 3.21% of the circulating market value, which is above the 50th percentile level over the past year, indicating a relatively high position [1]. - On the same day, Sichuang Medical repaid 1,400 shares in securities lending and sold 13,200 shares, with a selling amount of 57,400 yuan. The remaining securities lending volume was 66,000 shares, with a balance of 287,100 yuan, exceeding the 90th percentile level over the past year, indicating a high position [1]. Group 3 - As of September 30, the number of shareholders for Sichuang Medical was 58,400, a decrease of 11.34% from the previous period. The average circulating shares per person increased by 12.79% to 19,077 shares [2]. - For the period from January to September 2025, Sichuang Medical achieved an operating income of 604 million yuan, representing a year-on-year growth of 6.95%. However, the net profit attributable to the parent company was -4.76 million yuan, showing a year-on-year increase of 98.32% in losses [2]. Group 4 - Since its A-share listing, Sichuang Medical has distributed a total of 532 million yuan in dividends. However, there have been no dividend distributions in the past three years [3].